Page last updated: 2024-10-25

deferoxamine and Corynebacterium Infections

deferoxamine has been researched along with Corynebacterium Infections in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Corynebacterium Infections: Infections with bacteria of the genus CORYNEBACTERIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kazmierski, WM1
Wolberg, G1
Wilson, JG1
Smith, SR1
Williams, DS1
Thorp, HH1
Molina, L1

Other Studies

1 other study available for deferoxamine and Corynebacterium Infections

ArticleYear
Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Aug-20, Volume: 93, Issue:17

    Topics: Animals; Corynebacterium Infections; Deferoxamine; Electric Conductivity; Ferric Compounds; Iron Che

1996